Видео ютуба по тегу Interim Analysis

Online Yoga vs Diet & Brisk Walk for Hypertensive Elders: Analysis of RCT by Dr. Monika Pathania
Online Yoga vs Diet & Brisk Walk for Hypertensive Elders: Analysis of RCT by Dr. Monika Pathania
SPIRIT for Pragmatic Trial Protocols: Stats, Oversight, and Ethics (Part 3)
SPIRIT for Pragmatic Trial Protocols: Stats, Oversight, and Ethics (Part 3)
ISRE 2410 Review of interim financial Information Performed by the Independent Auditor of the entity
ISRE 2410 Review of interim financial Information Performed by the Independent Auditor of the entity
Krystal Biotech Positive Interim Clinical Update from KB407 Phase 1 CORAL 1 Study | Jan, 08 2026
Krystal Biotech Positive Interim Clinical Update from KB407 Phase 1 CORAL 1 Study | Jan, 08 2026
The generalisability of RCT an validity analysis of the SENOMAC trial
The generalisability of RCT an validity analysis of the SENOMAC trial
Interim clinical results by EyeCool show progress in treating patients with COSP
Interim clinical results by EyeCool show progress in treating patients with COSP
Interim analysis of a Phase II study of the GLOVe regimen in untreated, high-risk MCL
Interim analysis of a Phase II study of the GLOVe regimen in untreated, high-risk MCL
Apogee Therapeutics Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777) | Jan 06
Apogee Therapeutics Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777) | Jan 06
Dec2025-Interim Fire Rhetoric Analysis
Dec2025-Interim Fire Rhetoric Analysis
LC04 Чудо в исследованиях диабета. Надежда на будущее.
LC04 Чудо в исследованиях диабета. Надежда на будущее.
RADIOPHARM THERANOSTICS (RADX) Stock Analysis | Phase 2b Results & Market Update
RADIOPHARM THERANOSTICS (RADX) Stock Analysis | Phase 2b Results & Market Update
Gold chart interim analysis December 23, 2025
Gold chart interim analysis December 23, 2025
PCSA Stock Analysis (Processa Pharmaceuticals Stock) December 18, 2025
PCSA Stock Analysis (Processa Pharmaceuticals Stock) December 18, 2025
Processa Pharmaceuticals (NASDAQ: PCSA) Analysis | Clinical Update & Reverse Split News Today
Processa Pharmaceuticals (NASDAQ: PCSA) Analysis | Clinical Update & Reverse Split News Today
AFFU-AW study- interim analysis. (For RJS)
AFFU-AW study- interim analysis. (For RJS)
Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL
Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL
Multiple Speakers | Designing an adaptive trial with treatment selection and a survival endpoint
Multiple Speakers | Designing an adaptive trial with treatment selection and a survival endpoint
Prof. Allan Donner | The Role of Cluster Randomization Trials in Health Research
Prof. Allan Donner | The Role of Cluster Randomization Trials in Health Research
Открытый исследовательский офис CTSI: Advarra eSource + EDC
Открытый исследовательский офис CTSI: Advarra eSource + EDC
Amy McLemore, PhD: Interim analysis of largest scRNA-seq cohorts in chronic myeloid malignancies
Amy McLemore, PhD: Interim analysis of largest scRNA-seq cohorts in chronic myeloid malignancies